OBJECTIVE: Symptomatic hand osteoarthritis (OA) is a common condition that affects hand strength and function, and causes disability in activities of daily living. Prior studies have estimated that the lifetime risk of symptomatic knee OA is 45% and that of hip OA is 25%. The objective of the present study was to estimate the overall lifetime risk of symptomatic hand OA, and the stratified lifetime risk according to potential risk factors. METHODS: Data were obtained from 2,218 adult subjects (ages ≥45 years) in the Johnston County Osteoarthritis Project, a population-based prospective cohort study among residents of Johnston County, North Carolina. Data for the present study were collected from 2 of the follow-up cycles (1999-2004 and 2005-2010). Symptomatic hand OA was defined as the presence of both self-reported symptoms and radiographic OA in the same hand. Lifetime risk, defined as the proportion of the population who will develop symptomatic hand OA in at least 1 hand by age 85 years, was estimated from models using generalized estimating equations. RESULTS: Overall, the lifetime risk of symptomatic hand OA was 39.8% (95% confidence interval [95% CI] 34.4-45.3%). In this population, nearly 1 in 2 women (47.2%, 95% CI 40.6-53.9%) had an estimated lifetime risk of developing symptomatic hand OA by age 85 years, compared with 1 in 4 men (24.6%, 95% CI 19.5-30.5%). Race-specific symptomatic hand OA risk estimates were 41.4% (95% CI 35.5-47.6%) among whites and 29.2% (95% CI 20.5-39.7%) among African Americans. The lifetime risk of symptomatic hand OA among individuals with obesity (47.1%, 95% CI 37.8-56.7%) was 11 percentage points higher than that in individuals without obesity (36.1%, 95% CI 29.7-42.9%). CONCLUSION: These findings demonstrate the substantial burden of symptomatic hand OA overall and in sociodemographic and clinical subgroups. Increased use of public health and clinical interventions is needed to address its impact.
OBJECTIVE: Symptomatic hand osteoarthritis (OA) is a common condition that affects hand strength and function, and causes disability in activities of daily living. Prior studies have estimated that the lifetime risk of symptomatic knee OA is 45% and that of hip OA is 25%. The objective of the present study was to estimate the overall lifetime risk of symptomatic hand OA, and the stratified lifetime risk according to potential risk factors. METHODS: Data were obtained from 2,218 adult subjects (ages ≥45 years) in the Johnston County Osteoarthritis Project, a population-based prospective cohort study among residents of Johnston County, North Carolina. Data for the present study were collected from 2 of the follow-up cycles (1999-2004 and 2005-2010). Symptomatic hand OA was defined as the presence of both self-reported symptoms and radiographic OA in the same hand. Lifetime risk, defined as the proportion of the population who will develop symptomatic hand OA in at least 1 hand by age 85 years, was estimated from models using generalized estimating equations. RESULTS: Overall, the lifetime risk of symptomatic hand OA was 39.8% (95% confidence interval [95% CI] 34.4-45.3%). In this population, nearly 1 in 2 women (47.2%, 95% CI 40.6-53.9%) had an estimated lifetime risk of developing symptomatic hand OA by age 85 years, compared with 1 in 4 men (24.6%, 95% CI 19.5-30.5%). Race-specific symptomatic hand OA risk estimates were 41.4% (95% CI 35.5-47.6%) among whites and 29.2% (95% CI 20.5-39.7%) among African Americans. The lifetime risk of symptomatic hand OA among individuals with obesity (47.1%, 95% CI 37.8-56.7%) was 11 percentage points higher than that in individuals without obesity (36.1%, 95% CI 29.7-42.9%). CONCLUSION: These findings demonstrate the substantial burden of symptomatic hand OA overall and in sociodemographic and clinical subgroups. Increased use of public health and clinical interventions is needed to address its impact.
Authors: Amanda E Nelson; Yvonne M Golightly; Jordan B Renner; Todd A Schwartz; Virginia B Kraus; Charles G Helmick; Joanne M Jordan Journal: Arthritis Rheum Date: 2013-02
Authors: A Willemien Visser; Andreea Ioan-Facsinay; Renée de Mutsert; Ralph L Widya; Marieke Loef; Albert de Roos; Saskia le Cessie; Martin den Heijer; Frits R Rosendaal; Margreet Kloppenburg Journal: Arthritis Res Ther Date: 2014-01-22 Impact factor: 5.156
Authors: Margreth Grotle; Kare B Hagen; Bard Natvig; Fredrik A Dahl; Tore K Kvien Journal: BMC Musculoskelet Disord Date: 2008-10-02 Impact factor: 2.362
Authors: Terese R Gullo; Yvonne M Golightly; Rebecca J Cleveland; Jordan B Renner; Leigh F Callahan; Joanne M Jordan; Virginia B Kraus; Amanda E Nelson Journal: Semin Arthritis Rheum Date: 2018-10-09 Impact factor: 5.532
Authors: Zachary A Scherzer; Carolina Alvarez; Jordan B Renner; Louise B Murphy; Todd A Schwartz; Joanne M Jordan; Yvonne M Golightly; Amanda E Nelson Journal: J Rheumatol Date: 2020-02-15 Impact factor: 4.666
Authors: E A Snyder; C Alvarez; Y M Golightly; J B Renner; J M Jordan; A E Nelson Journal: Osteoarthritis Cartilage Date: 2020-02-19 Impact factor: 6.576
Authors: Terese R Gullo; Yvonne M Golightly; Portia Flowers; Joanne M Jordan; Jordan B Renner; Todd A Schwartz; Virginia B Kraus; Marian T Hannan; Rebecca J Cleveland; Amanda E Nelson Journal: BMC Musculoskelet Disord Date: 2019-04-11 Impact factor: 2.362
Authors: Lucy S Gates; Nigel K Arden; Marian T Hannan; Edward Roddy; Tiffany K Gill; Catherine L Hill; Alyssa B Dufour; Trishna Rathod-Mistry; Martin J Thomas; Hylton B Menz; Catherine J Bowen; Yvonne M Golightly Journal: Arthritis Care Res (Hoboken) Date: 2019-05 Impact factor: 5.178